Based on the new coronavirus transmission characteristics, pathogenicity and clinical information, the new coronavirus (SARS-Cov-2, hereinafter referred to as the new coronavirus) in accordance with the second category of pathogenic microorganisms for management. Please local health commission strictly require each biosafety laboratory in accordance with the following protection requirements to carry out related experimental activities: new coronavirus virus culture, animal infection experiments should be carried out in biosafety level 3 and above laboratories;
The operation of uncultivated infectious materials should be carried out in biosafety level 2 laboratories, while using biosafety level 3 laboratories personal protection; inactivation of the material operations should be carried out in biosafety level II laboratories; other operations such as molecular cloning that do not contain pathogenic live viruses can be carried out in biosafety level I laboratories.
EXTENDED INFORMATIONBased on the Biosafety Guidelines for Novel Coronavirus Laboratories (Second Edition), nucleic acid testing for novel coronaviruses should be performed in a Biosafety Level II laboratory, while using the personal protection of a Biosafety Level III laboratory.
Please local health commission proactively docking undertake new coronavirus nucleic acid testing of biosafety laboratories, do a good job of filing management, strengthen the technical guidance and proactive services, in order to enhance the jurisdiction of the new coronavirus nucleic acid testing capacity to provide a strong protection; local to guide the biosafety laboratories to standardize the operation process of the new coronavirus samples testing, and actively organize the development of the experimental operation techniques, personal protection, testing Sample disposal and other aspects of the training to enhance the nucleic acid testing personnel awareness of biosafety, to ensure the safety of testing personnel and the surrounding environment.
Dongfang.com-NHPC: NHPC: Strict Requirements for New Coronavirus Experimental Activities, Strengthening Management of Strains and Samples